Phase I and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignancies
Article
Xu, Y, Kolesar, JM, Schaaf, LJ et al. (2009). Phase I and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignancies
. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 63(6), 1073-1082. 10.1007/s00280-008-0826-3
Xu, Y, Kolesar, JM, Schaaf, LJ et al. (2009). Phase I and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignancies
. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 63(6), 1073-1082. 10.1007/s00280-008-0826-3